Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C T Fang

Showing results (11-20 of 78) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|March 7, 2001
Malaria eradication on islandsC T Fang, H L Chang, W C Hsieh
Transfusion Medicine Reviews|April 1, 1991
Human T-cell lymphotropic virus type I and II in transfusion medicineS G Sandler, C T Fang, A E Williams
Vox Sanguinis|January 1, 1976
Purification of hepatitis B surface antigen using polyethylene gylcol, pepsin and Tween 80N Nath, S Mazzur, R Ledman, et al.
Infection Control and Hospital Epidemiology|August 1, 1988
The American Red Cross experience with HTLV-IR Y Dodd, C T Fang, A E Williams
Lancet (London, England)|September 2, 1999
From effect size into number needed to treatC T Fang, W Y Sau, S C Chang
JAMA|March 12, 1982
Specificity of radioimmunoassay for hepatitis B e antigenN Nath, C T Fang, W Kline, et al.
Journal of Immunological Methods|January 1, 1978
A highly sensitive radioimmunoassay technique for subtyping the antibody to hepatitis B surface antigenC T Fang, N Nath, H Berberian, et al.
Journal of Virological Methods|June 1, 1981
A modified technique for the detection of hepatitis B virus-specific DNA polymeraseC T Fang, N Nath, M Pielech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2001
Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapyM Y Chen, C C Hung, C T Fang, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2001
Necessity of a loading dose when using vancomycin in critically ill patientsJ T Wang, C T Fang, Y C Chen, et al.
Pageof 8

Showing results (11-20 of 78) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|March 7, 2001
Malaria eradication on islandsC T Fang, H L Chang, W C Hsieh
Transfusion Medicine Reviews|April 1, 1991
Human T-cell lymphotropic virus type I and II in transfusion medicineS G Sandler, C T Fang, A E Williams
Vox Sanguinis|January 1, 1976
Purification of hepatitis B surface antigen using polyethylene gylcol, pepsin and Tween 80N Nath, S Mazzur, R Ledman, et al.
Infection Control and Hospital Epidemiology|August 1, 1988
The American Red Cross experience with HTLV-IR Y Dodd, C T Fang, A E Williams
Lancet (London, England)|September 2, 1999
From effect size into number needed to treatC T Fang, W Y Sau, S C Chang
JAMA|March 12, 1982
Specificity of radioimmunoassay for hepatitis B e antigenN Nath, C T Fang, W Kline, et al.
Journal of Immunological Methods|January 1, 1978
A highly sensitive radioimmunoassay technique for subtyping the antibody to hepatitis B surface antigenC T Fang, N Nath, H Berberian, et al.
Journal of Virological Methods|June 1, 1981
A modified technique for the detection of hepatitis B virus-specific DNA polymeraseC T Fang, N Nath, M Pielech, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2001
Reconstituted immunity against persistent parvovirus B19 infection in a patient with acquired immunodeficiency syndrome after highly active antiretroviral therapyM Y Chen, C C Hung, C T Fang, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2001
Necessity of a loading dose when using vancomycin in critically ill patientsJ T Wang, C T Fang, Y C Chen, et al.
Pageof 8